rapid development of symptomatic hiv-1 related disease in prostitutes in nairobi, kenya.

NLM AIDSLINE Rapid development of symptomatic HIV-1 related disease in prostitutes in Nairobi, Kenya. Anzala AO; Plummer FA; Ngugi EN; Emonyi W; Kreiss JK; Ndiny-Achola JO;
December 30, 1992

Int Conf AIDS. 1992 Jul 19-24;8(2):C303 (abstract no. PoC 4353). Unique OBJECTIVE: This study was designed to determine the incubation period and risks for development of HIV-1 related disease in a population of women with a known time of seroconversion. METHOD: A cohort of 163 women were enrolled at the time of seroconversion and followed for the occurrence of HIV-1 related illness at 6 months intervals for 12-60 months following seroconversion. Survival analysis were performed. HIV-1 related disease was classified using the CDC staging system. Lymphocyte subset determination were performed by flow cytometry. RESULTS: Of the 163 women identified 68 have developed stage 4A disease while 57 have developed stage 4C disease. The median time to development of stage 4A was 47.3 months with a mean time of 67.2 months. The median time to development of stage 4C disease was 51.1 months with a mean time of 86.3 months. Lymphocyte subset determination showed a close correlation between clinical staging and absolute CD4 counts. CONCLUSION: The incubation time to symptomatic disease is much shorter in this cohort of women as compared to other studies. This may have profound impacts on the course of the HIV epidemic in Africa. Cohort Studies CD4-Positive T-Lymphocytes Female Human HIV Infections/DIAGNOSIS/MORTALITY HIV Seropositivity/COMPLICATIONS HIV-1 Kenya/EPIDEMIOLOGY Leukocyte Count Lymphocyte Subsets Prostitution Survival Analysis Time Factors ABSTRACT

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV No time to lose in the search for an HIV vaccine India Widens Price Control Over Medicines Health group didn't disclose HIV tests, apologizes As Hepatitis C Spreads, Scotland Steps In Russia has 'no anti-AIDS strategy': official Uganda: Over 600 Circumcised in Masaka 1 new hepatitis case in Okla. public health scare NEW JERSEY: Drug Company Donates Thousands to HIV/AIDS Orgs People with HIV pay more for life insurance – if they can get it (South Africa)Uganda: Gov't Urged to Levy a Tax On Alcohol to Fund HIV No time to lose in the search for an HIV vaccine Health group didn't disclose HIV tests, apologizes NEW JERSEY: Drug Company Donates Thousands to HIV/AIDS Orgs PENNSYLVANIA: Scientists Weaken HIV Infection in Immune Cells Using Synthetic Agents Danish researchers issue statement: "We are not on the brink of an HIV cure"High school coach charged with sexual contact, transmitting HIV SOUTH AFRICA: AIDS-Related Deaths Falling in S. Africa: Agency CALIFORNIA: Oakland HIV/AIDS Housing the Focus of Meeting
Information in this article was accurate in December 30, 1992. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.